Abstract
Abstract Preeclampsia (PE) is a gestational hypertensive syndrome that affects approximately 2 to 8% of pregnant women and is one of the leading causes of maternal-fetal morbidity and mortality. The pathophysiology of PE involves abnormal placentation, endothelial dysfunction, and systemic inflammation, but effective pharmacological treatment is still lacking. The objective of this study …